trichostatin a
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 27, 2018 (NCT03838926)
Timeline
Indications
Studied for
Mechanism of action
- Histone deacetylase 6INHIBITOR
HDAC6 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07065773 | Phase 2 | May 5, 2025 | Vanda Pharmaceuticals |
| NCT03838926 | Phase 1 | Sep 27, 2018 | Vanda Pharmaceuticals |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Vanda Pharmaceuticals | For profit | 2 | 2 | 2 | 2018 |
1 organizations
Page 1 / 1